Viking Global Investors LP Adaptive Biotechnologies Corp Transaction History
Viking Global Investors LP
- $29.9 Billion
- Q1 2025
A detailed history of Viking Global Investors LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Viking Global Investors LP holds 29,993,708 shares of ADPT stock, worth $315 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
29,993,708
Previous 29,993,708
-0.0%
Holding current value
$315 Million
Previous $180 Million
23.83%
% of portfolio
0.74%
Previous 0.61%
Shares
3 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Rubric Capital Management LP New York, NY13.1MShares$138 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$122 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$117 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$81.2 Million0.62% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.64MShares$69.7 Million0.01% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.5B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...